CINDA INTL HLDG (00111) and CPI (China) Management Limited entered into a Shanghai Property rights trading contract.
China International Holdings (00111) announced that on November 13, 2024, the company received Shanghai United Equity...
CINDA INTL HLDG (00111) announced that on November 13, 2024, the company received a notification from the Shanghai United Property Exchange that the bidder submitted a bid of RMB 16.95 million for the public listing announcement on the sale of Cinda International Shanghai during the bidding period.
Based on this, on November 15, 2024, after the trading session, the company entered into a property transaction contract with the buyer, CPI (China) Management Limited, agreeing to sell and the buyer agreeing to purchase the equity of Cinda International Shanghai for RMB 16.95 million.
After the completion of the sale of Cinda International Shanghai, it will no longer be a subsidiary of the company, and its financial performance will no longer be consolidated into the group's financial statements.
The announcement stated that in order to optimize resources and streamline the group's structure, the company intends to sell the equity of Cinda International Shanghai. The sale of Cinda International Shanghai will help the group reallocate resources to other existing or market-oriented businesses. The board of directors believes that the sale of Cinda International Shanghai will provide a solid foundation for the group to achieve stable operations and promote sustainable development.
Related Articles

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.
GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025